Small intestinal bacterial overgrowth (SIBO) is a pathophysiological condition characterized by native and/or excessive growth of bacteria, which leads to disruption of the normal microflora and can cause various clinical manifestations. This condition is associated with a weight-related change in the composition of the bacterial population, which can lead to intestinal disorders, malabsorption and systemic disorders. The main symptoms of SIBO include flatulence, diarrhea, abdominal pain and steatorrhea. Studies show that this condition may be associated with a number of comorbidities, especially from the gastrointestinal tract, such as irritable bowel syndrome and Crohn's disease. Importantly, SIBO can be recurrent, which makes its careful diagnosis and adequate treatment especially important.
History of the disease and interesting historical facts
The history of small intestinal bacterial overgrowth research dates back to the mid-20th century, when the importance of bacterial flora in maintaining human health was recognized. At first, the emphasis was on the role of bacteria in digestion. In the 1950s, the first mentions of pathology associated with abnormal bacterial environment formation in the small intestine appeared. Interestingly, until that time, the small intestine was considered to be virtually sterile, and any deviations from the norm were inaccessible for study. With the advent of microbiological analysis and small intestinal sample testing, it became possible to describe and classify IBGR, which ultimately allowed the development of new approaches to its diagnosis and treatment.
Epidemiology
The epidemiology of small intestinal bacterial overgrowth remains an actively researched topic, but today some statistics are known indicating the prevalence of this condition. According to various estimates, SIBO occurs in 30-85% patients with various digestive disorders. The disease is most often diagnosed in middle-aged and elderly people, as well as in patients with chronic diseases such as diabetes and cirrhosis of the liver. According to studies, more than 50% patients with irritable bowel syndrome have signs of bacterial overgrowth. Being a common problem, SIBO requires the attention of specialists in the field of gastroenterology.
Genetic predisposition to this disease
Currently, genetic research shows that there are certain factors that predispose to the development of small intestinal bacterial overgrowth. In particular, polymorphisms of genes associated with immune responses and the structure of the intestinal mucosa have been studied. One of the main groups of genes involved includes genes responsible for the synthesis of immunoglobulins and antibodies, such as IGHE, as well as genes involved in interleukin signaling. Mutations in these genes can weaken the intestinal defense mechanisms, allowing pathogenic flora to flourish and cause IBS.
Risk factors for the development of this disease
Risk factors that contribute to the development of small intestinal bacterial overgrowth include both physical and chemical factors. The main ones are:
- Chronic diseases: diabetes, liver cirrhosis, pancreatic diseases.
- Problems with bowel motility, such as true or false reflux syndrome.
- Frequent and long courses of antibiotic therapy, which lead to dysbiosis and irreversible changes in microflora.
- Some surgical interventions on the gastrointestinal tract, in particular resection of the small intestine, cause disturbances of anatomy and function.
- A high-carbohydrate, low-fiber diet that encourages carbohydrate-predating microorganisms to predominate.
Diagnosis of this disease
Diagnosis of small intestinal bacterial overgrowth requires a comprehensive approach and involves a variety of methods. The main symptoms may vary, but include:
- Chronic abdominal pain.
- Flatulence and bloating.
- Dissertation and steatorrhea.
- Fatigue and weight loss.
Laboratory tests, such as stool analysis for fatty acids and carbohydrates, can help confirm the diagnosis. Radiological tests, such as X-rays with contrast or MRI, can provide visualization of the bowel. Other diagnostics include gastroscopy to directly collect samples, and breath tests that record the level of hydrogen in the patient’s exhaled breath. The differential diagnosis includes ruling out other conditions, such as Crohn’s disease and lactose intolerance.
Treatment
Treatment of small intestinal bacterial overgrowth involves a multidisciplinary approach. General recommendations include dietary modification aimed at reducing carbohydrate intake and increasing fiber intake. Pharmacological treatment, in turn, includes the use of antibiotics, such as rifaximin, which help reduce aberrant bacterial growth. Surgery may be indicated in cases where SIBO is caused by anatomical abnormalities or intestinal obstruction. Other treatments may include the use of probiotics to restore normal microbiota.
List of medications used to treat this disease
The main groups of drugs used in the treatment of IBC:
- Antibiotics: rifaximin, metronidazole.
- Probiotics: Lactobacillus, Bifidobacterium.
- Means for normalizing motivation: prokinetics such as domperidone and metoclopramide.
- Drugs to reduce the inflammatory response: corticosteroids for concomitant inflammatory bowel diseases.
Disease monitoring
Monitoring the condition of patients with IBC is important to assess the effectiveness of treatment and prevent relapses. Control stages include regular examinations by a gastroenterologist, stool tests and dietary recommendations. The prognosis in most cases depends on the cause of IBC and timely treatment. Complications are possible in the form of malabsorption, anemia and, in rare cases, toxic megacolon.
Age-related features of the disease
Small intestinal bacterial overgrowth can present differently depending on the age group. In children, the focus shifts to growth and developmental problems, while older patients tend to have more severe metabolic problems. In addition, older people often have a decreased immune response, which can contribute to a more severe course of the condition.
Questions and Answers
- What are the main symptoms of IBC? The main symptoms include abdominal pain, flatulence, diarrhea and steatorrhea.
- How is IBCR diagnosed? Diagnosis includes symptom analysis, laboratory tests, and radiological examinations.
- What are the treatments for IBC? Treatment includes diet therapy, pharmacological and surgical intervention.
- Can IBCR lead to complications? Yes, complications such as malabsorption and anemia are possible.
- How important is monitoring of the condition in IBC? Monitoring allows us to evaluate the effectiveness of treatment and prevent relapses of the disease.
